Current Liabilities decreased faster than Somalogic Inc 's Cash & cash equivalent, this led to improvement in Somalogic Inc 's Quick Ratio to 16.34, Quick Ratio remained below Somalogic Inc average.

Within Medical Laboratories industry 3 other companies have achieved higher Quick Ratio than Somalogic Inc in third quarter 2023. While Quick Ratio total ranking has improved so far during the Q3 2023 to 197, from total ranking in the second quarter 2023 at 213.

Explain Quick Ratio?
How much Cash & cash equivalents SLGC�s has?
What are SLGC�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SLGC Quick Ratio	(Sep 30 2023) Q3	(Jun 30 2023) Q2	(Mar 31 2023) Q1	(Dec 31 2022) Q4	(Sep 30 2022) Q3
Y / Y Current Liabilities Change	-34.9 %	-9.82 %	40.57 %	47.97 %	94.99 %
Y / Y Cash & cash equivalent Change	-19.87 %	-23.41 %	-22.73 %	-17.96 %	-16.19 %
Quick Ratio MRQ	16.34	15.05	12.88	12.45	13.27
SLGC's Total Ranking	# 197	# 213	# 267	# 278	# 293
Seq. Current Liabilities Change	-11.81 %	-18.96 %	-10.29 %	1.54 %	22.17 %
Seq. Cash & cash equivalent Change	-4.3 %	-5.27 %	-7.23 %	-4.72 %	-8.52 %

Quick Ratio third quarter 2023 Company Ranking
Within:	No.
Medical Laboratories Industry	# 4
Healthcare Sector	# 90
Overall Market	# 197

Quick Ratio Statistics
High	Average	Low
30.87	16.45	0.01
(Sep 30 2021)		(Jun 30 2021)

Financial Statements
Somalogic Inc 's Current Liabilities	$ 28 Millions	Visit SLGC's Balance sheet
Somalogic Inc 's Cash & cash equivalent	$ 454 Millions	Visit SLGC's Balance sheet
Source of SLGC's Sales		Visit SLGC's Sales by Geography

Cumulative Somalogic Inc 's Quick Ratio

SLGC's Quick Ratio for the trailling 12 Months

SLGC Quick Ratio	(Sep 30 2023) 12 Months	(Jun 30 2023) 12 Months	(Mar 31 2023) 12 Months	(Dec 31 2022) 12 Months	(Sep 30 2022) 12 Months
Y / Y Current Liabilities TTM Growth	5.16 %	37.47 %	16.41 %	35.16 %	46.47 %
Y / Y Cash & cash equivalent TTM Growth	-20.99 %	-19.98 %	9.72 %	61.86 %	145.85 %
Quick Ratio TTM	13.91	13.31	13.93	15.97	18.51
Total Ranking TTM	# 3086	# 3107	# 3086	# 2999	# 2870
Seq. Current Liabilities TTM Growth	-9.52 %	-2.15 %	7.55 %	10.44 %	18.28 %
Seq. Cash & cash equivalent TTM Growth	-5.41 %	-6.51 %	-6.21 %	-4.74 %	-4.21 %

Quick ratio ranking by company, industry and sector >> Back to SLGC Financial Strength Comparisons >> Go to Compare SLGC Quick Ratio to its Competitors

On the trailing twelve months basis Current Liabilities decreased faster than Somalogic Inc 's average Cash & cash equivalent, this led to increase in in Somalogic Inc 's Quick Ratio to 13.91, Quick Ratio remained below SLGC average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 40 other companies have achieved higher Quick Ratio than Somalogic Inc . While Quick Ratio overall ranking has improved so far to 3086, from total ranking during the twelve months ending second quarter 2023 at 3107.

Explain Quick Ratio?
How much Cash & cash equivalents SLGC�s has?
What are SLGC�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 41
Healthcare Sector	# 987
Within the Market	# 3086

trailing twelve months Quick Ratio Statistics
High	Average	Low
22.86	15.32	9.6
(Jun 30 2022)		(Dec 31 2021)

Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Medical Laboratories Industry	Quick Ratio	Sep 30 2023 MRQ Cash & cash equivalent	Sep 30 2023 MRQ Current Liabilities
Lightwave Logic Inc	35.39	$ 30.877 Millions	$ 0.873 Millions
Mdxhealth Sa	34.81	$ 22.380 Millions	$ 0.643 Millions
Check Cap Ltd	18.61	$ 24.756 Millions	$ 1.330 Millions
Somalogic Inc	16.34	$ 453.810 Millions	$ 27.781 Millions
Maxcyte inc	11.93	$ 190.240 Millions	$ 15.950 Millions
Celcuity Inc	10.70	$ 133.940 Millions	$ 12.522 Millions
Viridian Therapeutics Inc	8.77	$ 201.410 Millions	$ 22.959 Millions
Omniab Inc	6.79	$ 96.628 Millions	$ 14.226 Millions
Castle Biosciences Inc	6.33	$ 229.753 Millions	$ 36.324 Millions
Butterfly Network Inc	6.21	$ 150.006 Millions	$ 24.147 Millions
Nano X Imaging Ltd	5.62	$ 82.383 Millions	$ 14.663 Millions
Dermtech Inc	5.40	$ 68.200 Millions	$ 12.636 Millions
Guardant Health Inc	5.09	$ 1,154.821 Millions	$ 226.751 Millions
Veracyte Inc	4.05	$ 202.463 Millions	$ 50.039 Millions
Bionexus Gene Lab Corp	3.82	$ 6.147 Millions	$ 1.610 Millions
Science 37 Holdings Inc	3.76	$ 56.407 Millions	$ 15.020 Millions
Personalis Inc	3.72	$ 120.663 Millions	$ 32.478 Millions
Caredx Inc	3.69	$ 268.184 Millions	$ 72.674 Millions
Sera Prognostics Inc	3.40	$ 46.116 Millions	$ 13.545 Millions

Date modified: 2026-09-08T15:22:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.